Dacarbazine
SIGMA/D2390 - antineoplastic purine analog
Synonym: 5-
CAS Number: 4342-03-4
Empirical Formula (Hill Notation): C6H10N6O
Molecular Weight: 182.18
EC Number: 224-396-1
MDL Number: MFCD00057167
Linear Formula: C6H10N6O
Product Type: Chemical
| antibiotic activity spectrum | neoplastics |
| form | powder or crystals |
| InChI | 1S/C6H10N6O/c1-12(2)11-10 |
| InChI key | FDKXTQMXEQVLRF-ZHACJKMWSA |
| mode of action | DNA synthesis | interferes |
| Quality Level | 100 ![]() |
| SMILES string | CN(C)N=Nc1[nH]cnc1C(N)= |
| solubility | 1 M HCl: 50 mg/mL |
| storage temp. | 2-8°C |
| Application: | Dacarbazine is a triazine antineoplastic agent that is used for DNA methylation via formation of methyl adducts. It is used to treat metastatic malignant melanomas and Hodgkin′s when used in combination with other antineoplastic agents. |
| Biochem/physiol Actions: | Dacarbazine is a purine analog of naturally occurring purine precursor 5-amino-1H-imidazole-4-ca |
| Other Notes: | Keep container tightly closed in a dry and well-ventilated place. |
| Packaging: | 1 g in glass bottle |
| Packaging: | 100 mg in glass bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302 + H312 + H332 - H315 - H319 - H335 - H340 - H350 |
| Precautionary statements | P201 - P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 45-46-20/21/22-36/37/38 |
| Safety Statements | 53-36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 51102829 |



